Form 8-K - Current report:
SEC Accession No. 0001193125-24-259855
Filing Date
2024-11-15
Accepted
2024-11-15 16:31:29
Documents
15
Period of Report
2024-11-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d913169d8k.htm   iXBRL 8-K 32815
2 EX-1.1 d913169dex11.htm EX-1.1 235612
3 EX-5.1 d913169dex51.htm EX-5.1 7770
  Complete submission text file 0001193125-24-259855.txt   466190

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA iron-20241115.xsd EX-101.SCH 2866
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE iron-20241115_lab.xml EX-101.LAB 18738
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iron-20241115_pre.xml EX-101.PRE 11718
17 EXTRACTED XBRL INSTANCE DOCUMENT d913169d8k_htm.xml XML 3765
Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39438 | Film No.: 241468341
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)